| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10590996 | Bioorganic & Medicinal Chemistry Letters | 2014 | 5 Pages |
Abstract
A series of thienopyrimidine derivatives was synthesized and evaluated for their GPR119 agonistic ability. Several thienopyrimidine derivatives containing R1 and R2 substituents displayed potent GPR119 agonistic activity. Among them, compound 5d, which is a prototype, showed good in vitro activity with an EC50 value of 3Â nM and human and rat liver microsomal stability. Compound 5d exhibited no CYP inhibition and induction, Herg binding, or mutagenic potential. Compound 5d showed increase insulin secretion in beta TC-6 cell and lowered the glucose excursion in mice in an oral glucose-tolerance test.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Moon-Kook Jeon, Kyu Myung Lee, Il Hyang Kim, Yoon Kyung Jang, Seung Kyu Kang, Jun Mi Lee, Kwan-Young Jung, Jaladi Ashok Kumar, Sang Dal Rhee, Won Hoon Jung, Jin Sook Song, Myung Ae Bae, Kwang Rok Kim, Jin Hee Ahn,